| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000421 | WSYGAGIVLR | S | 2 | 425 |
| 10008880 | WSYGAGIVLR | S | 2 | 425 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000421 | MS | HTP | unambiguous | rat | heart | diabetic/control | -0.471305688 | 27213235 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
| 10008880 | MS | HTP | unambiguous | rat | heart (mitochondria) | 27213235 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000421 | WSYGAGIVLR | S | 2 | 425 | MS | HTP | unambiguous | rat | heart | 27213235 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. |
| 10008880 | WSYGAGIVLR | S | 2 | 425 | MS | HTP | unambiguous | rat | heart (mitochondria) | 27213235 |